← FDA DRUG APPROVALS

FDA ANDA · ANDA075928

CIPROFLOXACIN HYDROCHLORIDE

Sponsor: RUBICON RESEARCH

APPLICATION
ANDA075928
TYPE
ANDA
ORIGINAL APPROVAL
2004-06-09
LATEST ACTION
2011-05-25
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription

Products

CIPROFLOXACIN HYDROCHLORIDEPrescription
CIPROFLOXACIN HYDROCHLORIDE EQ 0.3% BASE · SOLUTION/DROPS · OPHTHALMIC

Approval history

2011-05-25Manufacturing (CMC) · Supplement 15AP
2005-04-22Labeling · Supplement 6AP
2004-06-09OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →